Long-acting GLP1-RA have many favorable properties and have clear efficacy data for reducing cardiovascular risks, as well as safety data, for their use in patients with T2D at high cardiovascular risk, including the subset of patients with DKD
From non-invasive body sculpting and Cryo therapy to energy work like Reiki and sound healing, every treatment is tailored to your unique needs
Following the positive REDEFINE 1 Phase 3 data (published June 2025, PMID: 40544433), Novo Nordisk announced plans to file regulatory applications for CagriSema for obesity in the United States (FDA), European Union (EMA), and other major markets in 20252026
39 A prospective study of patients with moderate-to-severe plaque psoriasis showed a higher percentage of dermal T cells in psoriatic plaques when compared to control
The patient will participate in a medically supervised treatment plan, which includes personalized nutritional guidance
Yes, it is important to work closely with your healthcare provider